Themis Medicare Faces Mixed Technical Trends Amid Market Volatility
2025-04-03 08:02:31Themis Medicare, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 150.00, showing a slight increase from the previous close of 148.00. Over the past year, Themis Medicare has experienced significant volatility, with a 52-week high of 313.65 and a low of 142.40. In terms of technical indicators, the weekly MACD remains bearish, while the monthly outlook is mildly bearish. The Relative Strength Index (RSI) indicates a bullish trend on a weekly basis, but shows no signal for the monthly period. Bollinger Bands and KST also reflect a mildly bearish sentiment in both weekly and monthly assessments. The moving averages indicate a bearish trend on a daily basis, while Dow Theory suggests a mildly bullish stance on a weekly basis. When comparing the stock's performance to the Sensex, The...
Read More
Themis Medicare Faces Continued Volatility Amid Declining Performance and Market Concerns
2025-03-17 13:35:51Themis Medicare has faced notable volatility, reaching a new 52-week low and underperforming its sector. The company's one-year performance shows a significant decline, with recent financial results raising concerns. Despite a low Debt to EBITDA ratio, the absence of domestic mutual fund investment indicates market apprehensions about its valuation.
Read More
Themis Medicare Faces Market Challenges Amid Significant Financial Declines and Volatility
2025-03-13 14:36:27Themis Medicare has faced notable volatility, reaching a new 52-week low and experiencing a significant decline over the past four days. The company has underperformed its sector, with a year-on-year performance drop and reduced cash reserves, indicating challenges in its financial health and market position.
Read More
Themis Medicare Faces Volatility Amid Significant Year-to-Date Decline in Stock Performance
2025-03-10 15:30:30Themis Medicare, a small-cap pharmaceutical company, faced a notable decline on March 10, 2025, reversing a brief upward trend. Despite recent volatility and underperformance compared to the broader market, the stock has shown significant long-term growth over the past five years. Year-to-date, it has declined substantially.
Read More
Themis Medicare Outperforms Sector Amid Broader Market Gains and Mixed Momentum Signals
2025-03-06 10:45:22Themis Medicare has experienced notable activity, gaining 7.01% on March 6, 2025, and outperforming the broader sector. The stock reached an intraday high of Rs 164.2, showing mixed short-term momentum. Despite recent gains, its longer-term performance reflects significant declines over the past month and year-to-date.
Read More
Themis Medicare Faces Significant Challenges Amidst Broader Market Volatility
2025-03-03 11:15:41Themis Medicare has faced notable challenges, with shares declining significantly and reaching a new 52-week low. The stock has underperformed its sector and experienced a consecutive decline over three days. Its performance contrasts sharply with the broader market, indicating ongoing difficulties in the current environment.
Read More
Themis Medicare Faces Significant Stock Volatility Amid Sustained Downward Trend
2025-03-03 10:06:14Themis Medicare, a small-cap pharmaceutical company, has hit a new 52-week low amid significant volatility, underperforming its sector. The stock has faced consecutive losses over three days and has declined sharply over the past year, trading below multiple moving averages, indicating ongoing challenges.
Read More
Themis Medicare Hits New Low Amid Ongoing Sector Challenges and Bearish Sentiment
2025-02-28 10:05:28Themis Medicare has reached a new 52-week low of Rs. 158.5, continuing a downward trend with a total decline of -6.96% over the past two days. The stock's one-year performance shows a drop of -32.61%, contrasting with the benchmark Sensex's gain of 1.81%.
Read More
Themis Medicare Shows Significant Rebound Amid Ongoing Market Challenges
2025-02-19 10:35:26Themis Medicare, a small-cap pharmaceutical company, saw a notable rebound on February 19, 2025, after eight days of decline. The stock reached an intraday high and experienced significant volatility, while its performance over the past month contrasts sharply with broader market trends.
Read MoreClosure of Trading Window
25-Mar-2025 | Source : BSEPlease refer to the attachment for further information.
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
24-Mar-2025 | Source : BSEPlease refer to the attachment.
Shareholder Meeting / Postal Ballot-Scrutinizers Report
24-Mar-2025 | Source : BSEPlease refer to the attachment.
Corporate Actions
No Upcoming Board Meetings
Themis Medicare Ltd has declared 50% dividend, ex-date: 12 Jul 24
Themis Medicare Ltd has announced 1:10 stock split, ex-date: 10 Oct 23
No Bonus history available
No Rights history available